AEterna Zentaris Inc (AEZS)
1.95
-0.01
(-0.34%)
USD |
NASDAQ |
Apr 19, 16:00
AEterna Zentaris Cash from Financing (TTM): -0.151M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.151M |
September 30, 2023 | -0.13M |
June 30, 2023 | -0.13M |
March 31, 2023 | -0.122M |
December 31, 2022 | -0.118M |
September 30, 2022 | 0.01M |
June 30, 2022 | 0.012M |
March 31, 2022 | 0.07M |
December 31, 2021 | 51.04M |
September 30, 2021 | 50.91M |
June 30, 2021 | 67.74M |
March 31, 2021 | 67.66M |
December 31, 2020 | 20.47M |
September 30, 2020 | 20.32M |
June 30, 2020 | 7.579M |
March 31, 2020 | 7.786M |
December 31, 2019 | 3.893M |
September 30, 2019 | 4.054M |
June 30, 2019 | 0.004M |
March 31, 2019 | -0.151M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 3.518M |
March 31, 2018 | 5.374M |
December 31, 2017 | 8.03M |
Date | Value |
---|---|
September 30, 2017 | 17.39M |
June 30, 2017 | 14.39M |
March 31, 2017 | 12.58M |
December 31, 2016 | 9.924M |
September 30, 2016 | 12.62M |
June 30, 2016 | 12.10M |
March 31, 2016 | 12.06M |
December 31, 2015 | 40.80M |
September 30, 2015 | 30.81M |
June 30, 2015 | 40.65M |
March 31, 2015 | 40.65M |
December 31, 2014 | 24.36M |
September 30, 2014 | 37.08M |
June 30, 2014 | 34.73M |
March 31, 2014 | 36.15M |
December 31, 2013 | 23.71M |
September 30, 2013 | 24.01M |
June 30, 2013 | 16.97M |
March 31, 2013 | 17.39M |
December 31, 2012 | 24.21M |
September 30, 2012 | 17.06M |
June 30, 2012 | 25.82M |
March 31, 2012 | 40.29M |
December 31, 2011 | 38.56M |
September 30, 2011 | 30.95M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.151M
Minimum
Dec 2023
67.74M
Maximum
Jun 2021
15.84M
Average
3.893M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |
Lexaria Bioscience Corp | 6.862M |
Xenon Pharmaceuticals Inc | 353.52M |